Ascend Wellness Holdings AAWH
OTC AAWH
$0.48 +0.02 (+5.47%)
As of: Aug 21, 2026 · 3:59 PM EDT

Ascend Wellness Holdings (AAWH) Non-Current Deferred Tax Liability (2020 - 2026)

Ascend Wellness Holdings (AAWH) posted quarterly Non-Current Deferred Tax Liability of $20.2 million for Q1 2026, down 14.17% year-over-year from $23.5 million in Q1 2025, and down 6.15% quarter-over-quarter from $21.5 million in Q4 2025.

Ascend Wellness Holdings (AAWH) Non-Current Deferred Tax Liability (2020 - 2026) Analysis & Trends

Ascend Wellness Holdings' Non-Current Deferred Tax Liability history runs 7 years deep, the most recent figure standing at $20.2 million for Q1 2026.

  • In Q1 2026, Non-Current Deferred Tax Liability fell 14.17% year-over-year to $20.2 million; the TTM figure through Mar 2026 stood at $20.2 million (down 14.17% YoY), while the FY2025 annual figure was $21.5 million, down 8.21% from the prior year.
  • Non-Current Deferred Tax Liability for Q1 2026 stood at $20.2 million, down from $21.5 million in the prior quarter.
  • The five-year high for Non-Current Deferred Tax Liability was $110.6 million in Q4 2023, with the low at $276000.0 in Q1 2022.
  • The 5-year median for Non-Current Deferred Tax Liability is $25.6 million (2024), against an average of $30.8 million.
  • The sharpest annual moves came in 2023 and 2024: Non-Current Deferred Tax Liability surged 11292.03% in 2023, then slumped 78.81% in 2024.
  • Ascend Wellness Holdings' Non-Current Deferred Tax Liability stood at $33.6 million in 2022, then soared by 229.18% to $110.6 million in 2023, then plunged by 78.81% to $23.4 million in 2024, then decreased by 8.21% to $21.5 million in 2025, then decreased by 6.15% to $20.2 million in 2026.
  • Business Quant data shows AAWH's Non-Current Deferred Tax Liability at $20.2 million in Q1 2026, $21.5 million in Q4 2025, and $18.7 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 44.51 Bn 43.55 Bn -
2 Teva Pharmaceutical Industries 43.52 Bn 39.86 Bn 2.15 Bn
3 Zoetis 32.43 Bn 30.75 Bn 1.05 Bn
4 Takeda Pharmaceutical 28.63 Bn 22.83 Bn 5.10 Bn
5 United Therapeutics 21.87 Bn 19.21 Bn 683.80 Mn
6 Viatris 18.98 Bn 18.09 Bn 1.46 Bn
7 Neurocrine Biosciences 15.43 Bn 15.04 Bn 935.80 Mn
8 Elanco Animal Health 12.02 Bn 11.49 Bn 798.00 Mn
9 Dr Reddys Laboratories 10.14 Bn 9.98 Bn -
10 Ascend Wellness Holdings 97.42 Mn 30.42 Mn 45.49 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 17.79 Mn
Jun 30, 2026 17.79 Mn
Mar 31, 2026 20.19 Mn
Mar 31, 2026 20.19 Mn
Dec 31, 2025 21.52 Mn
Dec 31, 2025 21.52 Mn
Sep 30, 2025 18.74 Mn
Sep 30, 2025 18.74 Mn
Jun 30, 2025 20.92 Mn
Jun 30, 2025 20.92 Mn
Mar 31, 2025 23.53 Mn
Mar 31, 2025 23.53 Mn
Dec 31, 2024 23.44 Mn
Dec 31, 2024 23.44 Mn
Sep 30, 2024 25.57 Mn
Sep 30, 2024 25.57 Mn
Jun 30, 2024 30.27 Mn
Jun 30, 2024 30.27 Mn
Mar 31, 2024 32.48 Mn
Mar 31, 2024 32.48 Mn